
Claudia Garbutt interviews Dr. Nisim Perets about using lab-grown brain tissue to predict drug responses for neurological conditions.
EPISODE SUMMARY What if we could predict whether a drug will work for a specific person before they ever take it? In this episode, Claudia Garbutt interviews Israeli neuroscientist and biotech entrepreneur Dr. Nisim Perets, founder of Itay&Beyond — a company pioneering patient-derived brain organoids on a chip to accelerate precision medicine for neurological and psychiatric conditions like Autism Spectrum Disorder and epilepsy. Dr. Perets and his team are growing miniature brain tissues from a patient's own cells, placing them on a chip, and measuring their electrical activity to predict how that specific brain might respond to medication. Yes — really. Mini Brains. Massive Breakthroughs. We talked about... Using lab-grown brain tissue to predict drug responses Neuroscience, nanoparticles & synthetic biology Precision medicine for autism, epilepsy, and psychiatric disorders EPISODE NOTES Dr. Nisim Perets is an Israeli neuroscientist and biotech entrepreneur specializing in drug development, targeted delivery systems, and advanced neurotechnologies. His work focuses on translating cutting-edge neuroscience into real-world therapeutic solutions, including patient-derived…
Host: Claudia Garbutt
Guest: Dr. Nisim Perets
Organizations: Itay&Beyond, NurExone Biologic
Explore listener stats, chart rankings, contacts and more on the Wired For Success: Success Mindset, High-Performance Habits, and Business Success for Entrepreneurs podcast page.